Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.

Prospective associations between meth/amphetamine (speed) and MDMA (ecstasy) use and depressive symptoms in secondary school students.

Brière FN, Fallu JS, Janosz M, Pagani LS.

J Epidemiol Community Health. 2012 Nov;66(11):990-4. doi: 10.1136/jech-2011-200706. Epub 2012 Apr 19.

PMID:
22516739
[PubMed - indexed for MEDLINE]
2.

Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.

Soar K, Turner JJ, Parrott AC.

J Psychopharmacol. 2006 May;20(3):417-24.

PMID:
16574716
[PubMed - indexed for MEDLINE]
3.

MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.

Clemens KJ, McGregor IS, Hunt GE, Cornish JL.

Drug Alcohol Rev. 2007 Jan;26(1):9-15. Review.

PMID:
17364831
[PubMed - indexed for MEDLINE]
4.

Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphetamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine.

Dalley JW, Lääne K, Theobald DE, Peña Y, Bruce CC, Huszar AC, Wojcieszek M, Everitt BJ, Robbins TW.

Neuropsychopharmacology. 2007 May;32(5):1195-206. Epub 2006 Oct 11.

PMID:
17035931
[PubMed - indexed for MEDLINE]
Free Article
5.

Psychosocial and behavioral correlates of depressed mood among female methamphetamine users.

Semple SJ, Zians J, Strathdee SA, Patterson TL.

J Psychoactive Drugs. 2007 Nov;Suppl 4:353-66.

PMID:
18284102
[PubMed - indexed for MEDLINE]
6.

Depressive symptomatology in young adults with a history of MDMA use: a longitudinal analysis.

Falck RS, Wang J, Carlson RG.

J Psychopharmacol. 2008 Jan;22(1):47-54. doi: 10.1177/0269881107078293.

PMID:
18187532
[PubMed - indexed for MEDLINE]
7.

Recreational ecstasy use and depression.

Guillot C, Greenway D.

J Psychopharmacol. 2006 May;20(3):411-6.

PMID:
16574715
[PubMed - indexed for MEDLINE]
8.

[Adolescents who have tried illicit drugs and experienced psychiatric symptoms seldom seek professional help. A pilot study of 18-year old high school students in an urban district].

Gunnarsson M, Fahlke C, Balldin J.

Lakartidningen. 2004 Apr 1;101(14):1280-2. Swedish.

PMID:
15101214
[PubMed - indexed for MEDLINE]
9.

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.

Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.

J Psychopharmacol. 2006 Mar;20(2):211-25. Review.

PMID:
16510479
[PubMed - indexed for MEDLINE]
10.

Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.

Kinner SA, Degenhardt L.

Drug Alcohol Rev. 2008 May;27(3):292-300. doi: 10.1080/09595230801919452.

PMID:
18368611
[PubMed - indexed for MEDLINE]
11.

Overview of amphetamine-type stimulant mortality data--UK, 1997-2007.

Schifano F, Corkery J, Naidoo V, Oyefeso A, Ghodse H.

Neuropsychobiology. 2010;61(3):122-30. doi: 10.1159/000279302. Epub 2010 Jan 29.

PMID:
20110737
[PubMed - indexed for MEDLINE]
12.

The epidemiology of methamphetamine use and harm in Australia.

Degenhardt L, Roxburgh A, Black E, Bruno R, Campbell G, Kinner S, Fetherston J.

Drug Alcohol Rev. 2008 May;27(3):243-52. doi: 10.1080/09595230801950572. Review.

PMID:
18368605
[PubMed - indexed for MEDLINE]
13.

Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms?

Guillot C.

J Psychoactive Drugs. 2007 Mar;39(1):31-9. Review.

PMID:
17523583
[PubMed - indexed for MEDLINE]
14.

Behavioral and social correlates of methamphetamine use in a population-based sample of early and later adolescents.

Embry D, Hankins M, Biglan A, Boles S.

Addict Behav. 2009 Apr;34(4):343-51. doi: 10.1016/j.addbeh.2008.11.019. Epub 2008 Nov 27.

PMID:
19138821
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The harmful health effects of recreational ecstasy: a systematic review of observational evidence.

Rogers G, Elston J, Garside R, Roome C, Taylor R, Younger P, Zawada A, Somerville M.

Health Technol Assess. 2009 Jan;13(6):iii-iv, ix-xii, 1-315. doi: 10.3310/hta13050. Review.

PMID:
19195429
[PubMed - indexed for MEDLINE]
Free Article
16.

Mental disorders in current and former heavy ecstasy (MDMA) users.

Thomasius R, Petersen KU, Zapletalova P, Wartberg L, Zeichner D, Schmoldt A.

Addiction. 2005 Sep;100(9):1310-9.

PMID:
16128720
[PubMed - indexed for MEDLINE]
17.

Relationship between ecstasy use and depression: a study controlling for poly-drug use.

Roiser JP, Sahakian BJ.

Psychopharmacology (Berl). 2004 May;173(3-4):411-7. Epub 2003 Dec 3.

PMID:
14652710
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.

Daumann J Jr, Fischermann T, Heekeren K, Thron A, Gouzoulis-Mayfrank E.

Biol Psychiatry. 2004 Sep 1;56(5):349-55.

PMID:
15336517
[PubMed - indexed for MEDLINE]
19.

Methamphetamine users show greater than normal age-related cortical gray matter loss.

Nakama H, Chang L, Fein G, Shimotsu R, Jiang CS, Ernst T.

Addiction. 2011 Aug;106(8):1474-83. doi: 10.1111/j.1360-0443.2011.03433.x. Epub 2011 May 12.

PMID:
21438934
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

'Ecstasy' and the use of sleep medications in a general community sample: a 4-year follow-up.

Tait RJ, George A, Olesen S.

Addiction. 2013 Sep;108(9):1640-8. doi: 10.1111/add.12200. Epub 2013 May 7.

PMID:
23651221
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk